Y0001001

泮托拉唑

European Pharmacopoeia (EP) Reference Standard

• 别名: Pantoprazole sodium hydrate, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt sesquihydrate, Pantoprazole sodium sesquihydrate, Pantozol sesquihydrate, Protonix sesquihydrate
• 经验公式（希尔记法）: C₁₆H₁₄F₂N₃NaO₄S
• CAS号: 138786-67-1
• 分子量: 405.35
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: pantoprazole
• 制造商/商品名称: EDQM
• 应用: pharmaceutical (small molecule)
• 包装形式: neat
• 储存温度: 2-8°C
• SMILES字符串: O.O.O.[Na+].[Na+].COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[n-]2)c1OC.COc4ccnc(CS(=O)c5nc6cc(OC(F)F)ccc6[n-]5)c4OC
• InChI: 1S/C16H14F2N3O4S.Na/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;/h3-7,15H,8H2,1-2H3;/q-1;+1
• InChI key: YNWDKZIIWCEDEE-UHFFFAOYSA-N

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Pantoprazole for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生化/生理作用

Gastric proton pump inhibitor.

Gastric proton pump inhibitor. It is used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

免责声明

sSales restrictions may apply.

安全信息

• 象形图: GHS07
• 警示用语：: Warning
• 危险声明: H302
• 预防措施声明: P301 + P312 + P330
• 危险分类: Acute Tox. 4 Oral
• 储存分类代码: 11 - Combustible Solids
• WGK: nwg
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable